Espergærde, Denmark

Per Balschmidt

This inventor holds 1 USPTO granted patent. Top assignee: Nordisk Insulinlaboratorium. Active years: 1986.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Per Balschmidt. Retrieved from https://idiyas.com/inventor/per-balschmidt-z6ooqx5c

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 6(Granted Patents)


Company Filing History:


Years Active: 1986

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Per Balschmidt

Introduction

Per Balschmidt is a notable inventor based in Espergarde, Denmark. He has made significant contributions to the field of biotechnology, particularly in the development of insulin. His work has had a profound impact on diabetes treatment and management.

Latest Patents

Per Balschmidt holds a patent for a "Process for preparing human insulin or B-30 esters thereof." This innovation is crucial for improving the efficiency and effectiveness of insulin production, which is vital for individuals with diabetes. He has 1 patent to his name, showcasing his expertise in this specialized area.

Career Highlights

Balschmidt is associated with Nordisk Insulinlaboratorium, a company renowned for its advancements in insulin production and diabetes care. His role at the company has allowed him to work on groundbreaking projects that enhance the quality of life for many patients.

Collaborations

Throughout his career, Per Balschmidt has collaborated with esteemed colleagues, including Finn H Andresen and Kim R Hejnos. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Per Balschmidt's contributions to the field of insulin production exemplify the importance of innovation in healthcare. His work continues to influence the lives of many individuals living with diabetes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…